http://www.editasmedicine.com
Editas Medicine, Inc. Company Intro
Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.
Industry
Healthcare
Editas Medicine, Inc. Headquaters
11 Hurley Street
Cambridge,02141
United States
Editas Medicine, Inc. Share price
14 Sep 2022 09:07 GMT
$15.25
-0.74 (-4.63 %)
Editas Medicine, Inc. Market cap
$1.013 B
WMC RANKING
2023
Editas Medicine, Inc. # 158
BiotechnologyLatest Editas Medicine, Inc. News
08 Feb 2023
Editas Medicine, Inc. Earnings Forecasted by Equities ...
Editas Medicine, INC is a pharmaceutical and biotechnology company. The forecasts made by R. Bienkowski, an analyst working at Cantor Fitzgerald,...
08 Feb 2023
Great West Life Assurance Co. Can Acquires New Position in ...
State Street Corp grew its holdings in Editas Medicine by 43.8% during the 2nd quarter. State Street Corp now owns 7,879,890 shares of the company's stock...
08 Feb 2023
Great West Life Assurance Co. Can Buys New Stake in Editas ...
BlackRock Inc. raised its holdings in shares of Editas Medicine by 15.5% in the first quarter. BlackRock Inc. now owns 6,275,270 shares of the company's stock...
WMC Market Score
WMC Market to Revenue Score
Editas Medicine, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Editas Medicine, Inc. | USD | $91,508 | $236,615 | $-134,980 | $10,130B | 158 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Editas Medicine, Inc. Social Followers vs Top 4 Industry Competitors
Editas Medicine, Inc. Post vs Top 4 Industry Competitors
Editas Medicine, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Editas Medicine, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Editas Medicine, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Editas Medicine, Inc. | 0.99 | 8.78 | 0.00 | 0 | 0 | 0 | 3.96 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
